Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Systems Biology|January 12, 2026
Unlocking CRISPR-Cas9 editing for widely diverse Dictyostelid speciesMireia Garriga-Canut, Nikki Cannon, Matt Benton, et al.
European Biophysics Journal : EBJ|April 21, 2021
Quality control of purified proteins to improve data quality and reproducibility: results from a large-scale surveyNick Berrow, Ario de Marco, Mario Lebendiker, et al.
Msystems|May 15, 2023
<i>In vitro</i> and <i>ex vivo</i> proteomics of <i>Mycobacterium marinum</i> biofilms and the development of biofilm-binding synthetic nanobodiesMilka Marjut Hammarén, Hanna Luukinen, Alina Sillanpää, et al.
Lancet Regional Health. Americas|October 23, 2023
Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohortRomain Fantin, Neha Agarwala, Amada Aparicio, et al.
European Journal of Medicinal Chemistry|November 4, 2022
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2Simone Di Micco, Rahila Rahimova, Marina Sala, et al.
The Journal of Biological Chemistry|September 9, 2021
Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motifRamiro Lorenzo, Lucas A Defelipe, Lucio Aliperti, et al.
STAR Protocols|November 2, 2023
A concise guide to choosing suitable gene expression systems for recombinant protein productionAnja Schütz, Frank Bernhard, Nick Berrow, et al.
Molecular Systems Biology|June 17, 2025
AlphaDesign: a de novo protein design framework based on AlphaFoldMichael A Jendrusch, Alessio L J Yang, Elisabetta Cacace, et al.
Cell|March 20, 2025
Jumbo phage killer immune system targets early infection of nucleus-forming phagesLi Yuping, Linlin Guan, Isabelle Becher, et al.
Nature Communications|November 5, 2020
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2Tânia F Custódio, Hrishikesh Das, Daniel J Sheward, et al.
Pageof 3